Académique Documents
Professionnel Documents
Culture Documents
Introduction
Jaundice is the yellow discoloration of the skin and sclera
in newborns caused by accumulation of bilirubin.1
Neonatal jaundice affects 60% of full-term infants and
80% of preterm infants in the first 3 days after birth.
Although transient, the condition accounts for up to
75% of hospital re-admissions in the first week of life.2
A study done in Canada showed that neonates with
severe hyperbilirubinaemia, total serum bilirubin TSB
.425 mmol/l, were predominantly term, male infants
who had been exclusively breastfed. The most common
aetiology was ABO incompatibility, followed by glucose6-phosphate dehydrogenase deficiency (G6PD).3 Similarly, a study in the UK and Ireland found that neonates
with a TSB >510 mmol/L tended to be term, male infants
who were predominantly breastfed. A haemolytic cause
for the jaundice was identified in nearly 50%.4
Additionally, researchers in the US found that neonates
with a TSB >513 mmol/L were mostly term infants and
infants who were exclusively breastfed.5
A review of cases of extreme hyperbilirubinaemia
(TSB >428 mmol/L) in Turkey showed that 96% of
the neonates were exclusively breastfed and that in
Methods
Correspondence to: H Trotman, Department of Child Health, University of
the West Indies, Mona, St Andrew, Jamaica.
Email: helen.trotmanedwards@uwimona.edu.jm
This was a retrospective, descriptive study looking at all neonates with a discharge diagnosis of
2012
VOL .
32
NO .
97
Extreme hyperbilirubinaemia
Ethical approval
The Ethics Committee of the University of the West
Indies/University Hospital of the West Indies,
Faculty of Medical Sciences granted approval for
this study to be conducted.
Results
During the study period, 170 neonates fulfilled the
inclusion criteria for the study; 139 (82%) were term
or near-term infants (gestational age >34 weeks).
Sixty-five (38%) patients were admitted from the
labour ward, 62 (37%) from the postnatal ward, 35
(20%) from home and 8 (5%) from other hospitals.
Fifteen (9%) neonates had extreme hyperbilirubinaemia (TSB >428 mmol/L). Maternal age ranged from
16 to 46 years with a mean (SD) of 29.4 (6.3) years.
Fifty-four per cent of the mothers were primiparous.
A significantly greater proportion of mothers of
infants with extreme hyperbilirubinaemia had labour augmented with oxytocin than mothers of
infants without extreme hyperbilirubinaemia (P,
0.05) (Table 1). The majority of mothers had blood
group O (66%). There were 20 (12%) rhesus-negative
mothers, but only four (3%) had a positive indirect
DCT. The infants of these four mothers did not
have extreme hyperbilirubinaemia.
The majority of infants were male 103 (61%). The
mean (SD) gestational age was 36.2 (3.1) weeks and
ranged from 24 to 41 weeks. One hundred and twelve
(66%) were delivered vaginally and 58 (34%) by
caesarean section. Birthweight ranged from 670 to
4830 g with a mean (SD) of 2696 (799) g. Term
infants accounted for 100% of infants with extreme
hyperbilirubinaemia while they accounted for only
53% of neonates without extreme hyperbilirubinaemia. Ninety-three per cent of neonates with extreme
hyperbilirubinaemia were exclusively breastfed compared with 49% of neonates who did not have
extreme hyperbilirubinaemia (P,0.01) (Table 2).
All three neonates with extreme hyperbilirubinaemia
who were dehydrated were exclusively breastfed while
Case definition
Any neonate admitted to the Newborn Special Care
Unit at the UHWI with a total serum bilirubin level
requiring investigation and medical intervention was
included. Medical intervention was defined as the
need for phototherapy, exchange transfusion or both.
Extreme hyperbilirubinaemia was defined as a TSB
level >428 mmol/L.
Exclusion criteria
Neonates who did not require medical intervention
and neonates who had a direct serum bilirubin level
.20% of the value of their total serum bilirubin level
were excluded.
Statistical analysis
Descriptive analyses were performed. Differences between the groups were determined using the x2 test for
categorical variables and Students t-test for continuous
variables. Factors associated with extreme hyperbilirubinaemia were determined using multiple logistic
16
16
8
35
(10)
(10)
(5)
(23)
100 (65)
55 (35)
* P,0.05
98
2012
VOL .
32
NO .
TSB(%)
>428 mmol/L
n515
5 (33)*
0
0
4 (27)
12 (80)
3 (20)
Male
Female
Preterm (,37 wks)
Term (>37 wks)
Cephalhaematoma
Excessive bruising
Exchange transfusion
Exclusive breastfeeding
Formula-fed/supplemented
Nil per orally
Dehydration on admission
with
hyperbiliru-
TSB (%)
,428 mmol/L
n5155
TSB (%)
>428 mmol/L
n515
93
62
73
82
3
10
6
75
35
44
16
10
5
0
15
1
0
3
14
1
0
3
(60)
(40)
(47)
(53)
(2)
(7)
(4)
(49)
(23)
(28)
(10)
(67)
(33)
(100)
(7)
(20)*
(93)*
(7)
(20)
* P,0.05
Extreme hyperbilirubinaemia
(SD) peak TSB for these five neonates was 473 (65)
mmol/L and all values fell within the top 5% of peak
TSB values for the study population. Of the 16
neonates for whom an aetiology for their hyperbilirubinaemia could not be found, only three (18%) were
tested for G6PD.
G6PD deficiency (4, 27%) and ABO incompatibility (6, 40%) together accounted for ten (67%) of
the cases of extreme hyperbilirubinaemia. Exclusive
breastfeeding, G6PD deficiency and augmentation of
labour with oxytocin were found to be significantly
associated with TSB levels >428 mmol/L (P,0.05).
One patient was discharged with a diagnosis of
bilirubin encephalopathy but was lost to follow-up;
this was a 32-week premature infant whose TSB was
317 mmol/L and who had received an exchange
transfusion. There were two deaths, but these were
related to extreme prematurity and not directly to
hyperbilirubinaemia; neither neonate had extreme
hyperbilirubinaemia. Sixty-two patients (37%) were
followed up at the outpatient clinic at UHWI, six of
whom were in the extreme hyperbilirubinaemia
group. Thirty (50%) had hearing tests done and they
were all normal, two were from the extreme
hyperbilirubinaemia group. Sixty-one (98%) had
normal development at the time of the study; one
patient who did not have extreme hyperbilirubinaemia had impaired motor development but this infant
also had a myelomeningocele.
Significant factors associated with extreme hyperbilirubinaemia were offered into a multiple logistic
regression model; neonates who were exclusively
breastfed were more likely to have extreme hyperbilirubinaemia than those who were formula-fed or
supplemented (OR 2.6, 95% CI 0.010.6). Mothers
who received oxytocin during labour were more likely
to have extreme hyperbilurubinaemia (OR 1.7, 95%
CI 0.040.8) and neonates who were G6PD-deficient
were more likely to have extreme hyperbilurubinaemia (OR 2.4, 95% CI 0.010.6) than those whose
mothers did not receive oxytocin and those who were
not G6PD-deficient.
Discussion
Similar to previous studies, we found that neonates
with extreme hyperbilirubinaemia tended to be
1.5
2.2
305
328
4.6
4.3
2.4
434
470
5.6
(2)
(0.7)
(89)
(54)
(2.0)
(4)*
(0.6)
(98){
(53){
(4.0)
P,0.001
2012
VOL .
32
NO .
99
Extreme hyperbilirubinaemia
exclusively-breastfed, male, term infants.35 In keeping with other studies, we found that ABO incompatibility was the most common underlying aetiology.3,4
Unlike previous Jamaican studies, rhesus iso-immunization was not a major cause of hyperbilirubinaemia,
and this probably reflects the efficacy of Rhogam use
in our population.8,9
Jamaica followed the recommendations of the
Innocenti Declaration in support of breastfeeding
and has adopted the Baby-Friendly Hospital
Initiative. Our study demonstrated that exclusively
breastfed neonates were three times more likely to
develop extreme hyperbilirubinaemia than those who
were formula-fed or supplemented. This association
between jaundice and breastfeeding has been documented in other studies.6,1013
Nineteen infants were dehydrated, the majority of
whom were being exclusively breastfed. Dehydrated
neonates with extreme hyperbilirubinaemia had greater weight loss on admission. Weight loss has been cited
in other studies as a risk factor for hyperbilirubinaemia, as a function of decreased energy and fluid
intake.11,14 Almost half of the dehydrated infants were
admitted from the postnatal ward. This might indicate
that monitoring of breastfeeding on the postnatal
ward is not as rigorous as it should be. Therefore, the
recognition of infants with difficulty breastfeeding in
the first 48 hours of life and the implementation of
breastfeeding support and supplementation, if medically indicated, needs to be more energetically pursued
on the postnatal ward.
This study shows that G6PD-deficient neonates
were twice as likely to develop extreme hyperbilirubinaemia. Only 26% of the neonates were tested for
G6PD deficiency and only 18% of the neonates in the
idiopathic group were tested. It is quite possible that,
if all the neonates in the study population, in
particular the males, had been tested, there would
have been a greater incidence than the 5% recorded.
In Trinidad, an incidence of 21% for G6PD deficiency was seen in infants with hyperbilirubinaemia.15
In 1972 it was reported that the incidence of G6PD
deficiency in jaundiced infants at UHWI was 20.5%.9
Aetiology
TSB (%)
TSB (%)
,428 mmol/L >428 mmol/L
n5155
n515
ABO incompatibility
Prematurity
Idiopathic
G6PD deficiency
Rhesus incompatibility
Culture-positive sepsis
Minor blood group incompatibility
53
19
14
4
6
5
4
(34)
(12)
(9)
(3)
(4)
(3)
(3)
6
0
2
4
0
1
0
(40)
(13)
(27)*
(7)
* P,0.001
100
2012
VOL .
32
NO .
References
1 Stoll B, Kliegman R. Jaundice and hyperbilirubinemia in the newborn.
In: Behrman RE, Kliegman, Jenson HB, eds. Nelson Textbook of
Pediatrics. Philadelphia, PA: WB Saunders, 2004; pp 5928.
2 Britton JR, Britton HL, Beebe SA. Early discharge of the term
newborn: a continued dilemma. Pediatrics. 1994;94:2915.
3 Sgro M, Campbell D, Shah V. Incidence and causes of extreme
neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175:58790.
4 Manning D, Todd P, Maxwell M, Platt MJ. Prospective
surveillance study of extreme hyperbilirubinaemia in the
newborn in the UK and Ireland. Arch Dis Child Fetal
Neonatal Ed. 2007;92:F3426.
5 Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin
levels of 30 mg/dL or more in a large managed care
organization. Pediatrics. 2003;111:130311.
6 Tiker F, Hande G, Hasan K, Aylin T, Berkan G. Extreme
hyperbilirubinemia in newborn infants. Clin Pediatr. 2006;
45:25761.
7 Salas A, Mazzil E; Exchange transfusion in infants with
extreme hyperbilirubinemia: an experience from a developing
country. Acta Pdiatr. 2008;97:7548.
Extreme hyperbilirubinaemia
2012
VOL .
32
NO .
101
Copyright of Paediatrics & International Child Health is the property of Maney Publishing and its content may
not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written
permission. However, users may print, download, or email articles for individual use.